Liver disease treatment can be “fast-acting”? Source: Chinese Liver Disease Net Publisher: Li Yankun Time: 2009-5-11 11:18:07 Read: 83 times Chinese Liver Disease Net comprehensive report: advertisements trumpeted the “special effects”, “quick effect” treatment of hepatitis, specializing in hepatitis, but can not do. Tertiary hospitals are unable to do. In this regard, experts say, “special effects”, “fast-acting” treatment of hepatitis has no scientific basis. Recently, there are hepatitis patients flocked to the Nanjing Second Hospital, asking the hospital experts to give “special effects” and “fast-acting” treatment, unwilling to accept the original step-by-step but very slow therapy, when the negative answer, the patient said doubtfully, some small hospitals and Outpatient clinics, and even some pharmaceutical companies have advertisements promising “special effects” and “fast-acting” treatment of hepatitis, the hall of tertiary specialized hospitals can not even reach this high level? In this regard, China’s well-known liver disease experts, Nanjing Second Hospital Chief Physician Professor Sun Xibin said that modern medicine still can not do in the treatment of hepatitis, “special effects” and “fast-acting” to drug treatment of hepatitis B, for example, the treatment of acute hepatitis B is mainly to support and symptomatic medication, to avoid the use of drugs, and to avoid the use of drugs. The treatment of acute hepatitis B is mainly supportive and symptomatic, and drug abuse should be avoided; for chronic hepatitis B, comprehensive treatment should be adopted, such as anti-virus, adjusting immunity, protecting hepatocytes, preventing fibrosis and improving microcirculation. Even with the use of long-acting interferon, which is currently recognized as having a strong antiviral effect, and some of the latest direct antiviral drugs, a certain degree of efficacy can only be achieved after three months, and the treatment process is also generally longer. Moreover, so far, the real can make the hepatitis B surface antigen (HBsAg) turn negative drug has not, all claim to be able to “turn negative” of the therapy or drug are lack of scientific basis, the patient can not be trusted. Zhangqiu People’s Hospital, Department of Infectious Diseases, Li Yuerong